MONDAY, Nov. 10, 2025 (Health News) — Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall.  Sun Pharmaceutical Industries has issued a voluntary, nationwide recall for several lots of lisdexamfetamine dimesylate capsules, a generic version of an ADHD treatment prescribed for people over…  read on >  read on >

If a healthy slurp is your aim, skip the banana when you whip up a smoothie. Researchers at the University of California-Davis found that adding banana may interfere with absorption of powerful compounds called flavanols, which are linked to brain and heart health. “We were really surprised to see how quickly adding a single banana…  read on >  read on >

A new screening tool may help doctors and communities better understand why so many Americans struggle to eat a healthy diet, even when they have enough food. Researchers at Tufts University’s Food is Medicine Institute in Boston have created and tested a survey called the Nutrition Security Screener (NSS). Unlike standard food security tools that…  read on >  read on >

Treatment with an experimental peanut protein patch can help young children safely build tolerance to peanuts, a new study says. More than 70% of children treated with the Viaskin Peanut Patch could tolerate at least three to four peanut kernels without a reaction after three years, researchers are scheduled to report Saturday in Orlando at…  read on >  read on >

Losing weight is considered one way to improve male fertility, but how guys drop pounds also matters, a new evidence review says. Men who lost weight through diet and exercise did wind up with better sperm quality, even with modest weight loss, researchers recently reported in the journal Human Reproduction Update. However, losing weight through…  read on >  read on >

The head of the U.S. Food and Drug Administration’s (FDA) drug division has resigned while under internal investigation, saying he was pushed out after raising concerns about how the agency planned to fast-track some new drugs. Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported.  His resignation…  read on >  read on >